Publications by authors named "Lisa M Demeter"

Claim this Profile
C
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.
Mary A Vogler, Laura M Smeaton, Rodney L Wright, Sandra W Cardoso, Jorge Sanchez, Lisa M Demeter

J Acquir Immune Defic Syndr· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.
Xinyan Zhang, Camlin Tierney, Mary Albrecht, Lisa M Demeter, Gene Morse

Ther Drug Monit· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.
Mary Albrecht, A Lisa Mukherjee, Camlin Tierney, Gene D Morse, Carrie Dykes, Lisa M Demeter

HIV Clin Trials· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection.
Jiong Wang, Gang Zhang, Robert A Bambara, Dongge Li, Hua Liang, Lisa M Demeter

J Virol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.
Elizabeth Connick, Ronald J Bosch, Evgenia Aga, Rick Schlichtemeier, Lisa M Demeter

J Acquir Immune Defic Syndr· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.
Scott M Hammer, Heather Ribaudo, Roland Bassett, John W Mellors, Lisa M Demeter

HIV Clin Trials· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequences in the U3 region of human immunodeficiency virus 1 improve efficiency of minus strand transfer in infected cells.
Dorota Piekna-Przybylska, Carrie Dykes, Lisa M Demeter, Robert A Bambara

Virology· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays.
Carrie Dykes, Hulin Wu, Matthew Sims, Jeanne Holden-Wiltse, Lisa M Demeter

J Clin Microbiol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions.
Jiong Wang, Robert A Bambara, Lisa M Demeter, Carrie Dykes

J Virol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy.
Viktor von Wyl, Maryam Ehteshami, Lisa M Demeter, Philippe Bürgisser, Monique Nijhuis

Clin Infect Dis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.
Carrie Dykes, A Lisa Mukherjee, Ronald J Bosch, Elizabeth Connick, Paul A Volberding, Lisa M Demeter

J Acquir Immune Defic Syndr· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assessment for therapeutic drug monitoring in AIDS Clinical Trials Group (ACTG 5146): a multicenter clinical trial.
Robin DiFrancesco, Susan Rosenkranz, A Lisa Mukherjee, Lisa M Demeter, Hongyu Jiang

Ther Drug Monit· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase.
Viktor von Wyl, Maryam Ehteshami, Jori Symons, Philippe Bürgisser, Monique Nijhuis, Lisa M Demeter

J Infect Dis· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.
Rajesh T Gandhi, Ronald J Bosch, Evgenia Aga, Mary Albrecht, Lisa M Demeter

J Infect Dis· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential equation modeling of HIV viral fitness experiments: model identification, model selection, and multimodel inference.
Hongyu Miao, Carrie Dykes, Lisa M Demeter, Hulin Wu

Biometrics· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients.
Lisa M Demeter, Hongyu Jiang, A Lisa Mukherjee, Gene D Morse, Robin DiFrancesco

AIDS· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments.
Hongyu Miao, Carrie Dykes, Lisa M Demeter, James Cavenaugh, Sung Yong Park

Bull Math Biol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.
Lisa M Demeter, Victor DeGruttola, Stephanie Lustgarten, Daniel Bettendorf, Margaret Fischl

HIV Clin Trials· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients.
Lisa M Demeter, A Lisa Mukherjee, Robin DiFrancesco, Hongyu Jiang, Robert DiCenzo

HIV Clin Trials· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of human immunodeficiency virus type 1 replication fitness.
Carrie Dykes, Lisa M Demeter

Clin Microbiol Rev· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.
Margaret A Fischl, Ann C Collier, A Lisa Mukherjee, Judith E Feinberg, Lisa M Demeter

AIDS· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V.
Christine E Koval, Carrie Dykes, Jiong Wang, Lisa M Demeter

Virology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 reverse transcriptase mutants resistant to nonnucleoside reverse transcriptase inhibitors do not adversely affect DNA synthesis: pre-steady-state and steady-state kinetic studies.
Robert A Domaoal, Robert A Bambara, Lisa M Demeter

J Acquir Immune Defic Syndr· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York.
Amneris E Luque, Musaret Jabeen, Susan Messing, Christopher A Lane, Lisa M Demeter

J Infect Dis· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture.
Carrie Dykes, Jiong Wang, Xia Jin, Vicente Planelles, Dong Sung An, Lisa M Demeter

J Clin Microbiol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis